ABUS vs TOUR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

ABUS

55.5
AI Score
VS
TOUR Wins

TOUR

67.1
AI Score

Investment Advisor Scores

ABUS

56score
Recommendation
HOLD

TOUR

67score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ABUS TOUR Winner
Revenue 14.08M 82.65M TOUR
Net Income -33.50M 4.45M TOUR
Net Margin -237.9% 5.4% TOUR
Operating Income -38.16M 1.61M TOUR
ROE -43.7% 3.0% TOUR
ROA -35.4% 1.9% TOUR
Total Assets 94.62M 228.79M TOUR
Cash 18.01M 29.63M TOUR
Current Ratio 15.73 2.04 ABUS

Relative Price Performance (Last 90 Days)

ABUS 1M: -3.8% · 3M: -13.7% TOUR 1M: -5.3% · 3M: -4.3%

Current Technical Phase

ABUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.2 · Price: $4.03

TOUR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.5%), weak momentum, RSI 41

RSI (14): 40.9 · Price: $4.69

Fundamentals Snapshot

Metric ABUS TOUR
Market Cap — —
Forward P/E -36.3 2.4
Trailing P/E 3.5 18.2
Revenue (TTM) — —
Revenue Growth -0.4% 0.0%
Gross Margin 0.9% 0.6%
Operating Margin 0.8% 0.0%
EPS 1.12 0.26
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TOUR is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.